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Brief Report  
Human Cdc14A Reverses CDK1 Phosphorylation of Cdc25A on Serines 
115 and 320 
ABStrACt
Human Cdc14A is an evolutionary conserved dual‑specificity protein phosphatase that 
reverses the modifications effected by cyclin‑dependent kinases and plays an important 
role in centrosome duplication and mitotic regulation. Few substrates of Cdc14A have 
been identified, some of them with homologues in yeast that, in turn, are substrates of the 
Saccharomyces cerevisiae Cdc14 homologue, a protein phosphatase essential for yeast 
cell viability owing its role in mitotic exit regulation. Identification of the physiological 
substrates of human Cdc14A is an immediate goal in order to elucidate which cellular 
processes it regulates. Here, we show that human Cdc14A can dephosphorylate Cdc25A 
in vitro. Specifically, the Cdk1/Cyclin‑B1‑dependent phosphate groups on Ser115 and 
Ser320 of Cdc25A were found to be removed by Cdc14A. Cdc25A is an important 
cell cycle‑regulatory protein involved in several cell cycle transitions and checkpoint 
responses and whose function and own regulation depend on complex phosphorylation/
dephosphorylation‑mediated processes. Importantly, we also show that the upregulation 
of Cdc14A phosphatase affects Cdc25A protein levels in human cells. Our results suggest 
that Cdc14A may be involved in the cell cycle regulation of Cdc25A stability.
iNtroDuCtioN
The	 dual-specificity	 phosphatase	 Cdc14	 is	 conserved	 from	 yeast	 to	 mammals	 and	 is	
involved	in	a	variety	of	functions	controlling	the	cell	division	cycle.	Cdc14	is	essential	for	
the	survival	of	S. cerevisiae	since	it	is	required	for	the	cell	to	exit	from	mitosis.1,2	ScCdc14	
dephosphorylates	 and	 activates	 several	 Cdk1/Cdc2	 substrates	 such	 Hct1/Cdh1	 protein,	
a	 component	 of	 the	 anaphase	 promoting	 complex/cyclosome	 (APC/C),	 or	 the	 Cdk1	
inhibitor	Sic1p,	in	both	cases	to	downregulate	Cdk1	activity	at	the	end	of	mitosis.2-4	In	
Schizosaccharomyces pombe,	 the	 Cdc14	 homologue	 Flp1/Clp15,6	 also	 regulates	 mitotic	
events,	 although	 through	 a	 distinct	 mechanism.	 Flp1/Clp1	 antagonizes	 mitotic	 CDK	
activity	 by	 dephosphorylation	 and	 subsequent	 degradation	 of	 SpCdc25,	 the	 inducer	 of	
mitotic	kinase,	and	also	substrate	of	Cdk1/Cdc2.7,8	Homologues	of	Cdc14	with	roles	in	
cell	division	processes	and	cytokinesis	have	also	been	identified	in	Caenorhabditis elegans	
and	Xenopus.9-11	In	human	cells,	two	Cdc14	isoforms	-Cdc14A	and	Cdc14B-	have	been	
identified.12	The	function	of	these	phosphatases	remains	poorly	understood,	although	it	is	
known	that	Cdc14A	plays	an	important	role	in	the	centrosome	cycle	and	mitotic	regula-
tion.13,14	An	important	goal	to	elucidate	the	functions	of	human	Cdc14	phosphatases	is	
the	identification	of	their	substrates.	A	few	substrates	for	Cdc14A	have	been	described,	and	
these	include	Cdh1/Hct1	and	INCENP	proteins15,16	and	the	tumor	suppressor	p53.17,18	
Moreover,	human	Cdc14A	can	rescue	flp1/clp1	deficiency	and	dephosphorylate	SpCdc25	
protein,19	 suggesting	 that	 some	conserved	mechanisms	must	 exist	with	 the	 fission	yeast	
Cdc14	homologue.	Mammalian	cells	have	three	Cdc25	isoforms;	Cdc25A,	B	and	C.20-22	
All	three	are	dual-specificity	phosphatases	that	activate	their	physiological	substrates,	the	
CDKs,23	although	each	Cdc25	family	member	has	unique	characteristics	and	specific	roles	
in	cell	cycle	regulation.
Here,	 we	 show	 that	 human	 Cdc14A	 can	 dephosphorylate	 Cdc25A	 on	 Ser115	 and	
Ser320,	two	Cdk1/Cyclin-B1	phosphorylation	sites,	and	that	these	protein	modifications	
are	involved	in	the	stability	of	Cdc25A.
[Cell	Cycle	5:24,	2894-2898,	15	December	2006];	©2006	Landes	Bioscience
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MAtEriAlS AND MEthoDS
Kinase and phosphatase assay.	 Wild-type	 or	 Cdc25A	 protein	
mutants	were	expressed	and	purified	from	E. coli	as	GST-Cdc25A	fusion	
proteins	 (GST-Cdc25A,	GST-Cdc25A(1-100),	GST-Cdc25A(101-523),	
GST-Cdc25AS115A,	 GST-Cdc25AS320A	 and	 GST-Cdc25AS115-320A)	
using	 a	pGEX-4T	vector	 (the	 full-length	pGEX-4T-Cdc25A	was	 a	
gift	 from	 P.	 Lazo´s	 laboratory).	The	 constructs	 for	 GST-hCdc14A	
and	its	phosphatase-inactivating	mutant,	GST-Cdc14A-CS,	with	the	
cysteine	 278	 mutated	 to	 serine,	 have	 been	 described	 previously.19	
GST-purification	 was	 carried	 out	 as	 previously	 described.24	 The	
CDK	substrates,	GST-Cdc25A	constructs,	were	incubated	with	2U	
of	Cdk1/cyclin-B1	human	complex	(New	England	Biolabs)	in	kinase	
buffer	(50	mM	Tris,	pH	7.5,	10	mM	MgCl2,	1	mM	EGTA,	1	mM	
DTT	and	50	mM	ATP)	in	the	presence	of	0.15	mCi	of	g(32P)ATP	
for	 30´	 at	 30˚C.	 When	 kinases	 assays	 were	 performed	 for	 mass	
spectrometry,	 only	 cold	ATP	was	used.	 Samples	were	 then	washed	
three	 times	 with	 1	 ml	 of	 phosphatase	 buffer	 (50	 mM	 imidazole,	
pH	 6.9,	 1	 mM	 EDTA,	 and	 1	 mM	 DTT)	 and	 GST-hCdc14	 was	
added	 and	 incubated	 for	 40´	 at	 30˚C.	 Reactions	 were	 stopped	 by	
the	 addition	 of	 loading	 buffer	 and	 boiling	 for	 5´at	 95˚C.	 Proteins	
were	resolved	by	SDS-PAGE	and	visualized	by	autoradiography	and	
Comassie	staining.
Characterization of phosphorylation by mass spectrometry. 
Protein	 bands	 were	 incubated	 for	 several	 minutes	 in	 ultra-pure	
water	and	digested	according	with	protocol	of	Schevchenko	et	al25	
with	some	minor	variations.	Gel	pieces	were	equilibrated	in	50	mM	
ammonium	 bicarbonate	 (ABC)	 prior	 to	 reduction	 with	 10	 mM	
DTT	and	alkylation	with	100	mM	iodoacetamide,	both	in	50	mM	
ABC.	Modified	porcine	trypsin	at	a	final	concentration	of	0.4	mg	per	
reaction	in	50	mM	ABC	was	added	to	dried	bands	and	the	digestion	
proceeding	at	37˚C	overnight.	Finally,	tryptic	peptides	were	extracted	
with	0.5%	trifluoroacetic	acid.	The	resulting	tryptic	peptides	were	on	
line	injected	onto	a	C-18	reversed-phase	nano-column	(Discovery®	
BIO	Wide	pore,	Supelco,	Bellafonte,	PA)	 and	analyzed	 in	 a	 conti-
nous	acetonitrile	gradient.	A	flow	rate	of	ca.	300	nl/min	was	used	to	
elute	peptides	from	the	reversed-phase	nano-column	to	a	PicoTip™	
emitter	 nano-spray	 needle	 (New	 Objective,	 Woburn,	 MA)	 for	
real-time	 ionization	and	precursor	 ion	scanning	analysis	on	a	4000	
Q-Trap	 LC-MS/MS	 hybrid	 system	 (Applied	 Biosystems,	 MDS,	
Sciex)	mass	spectrometer.
Plasmids, mutagenesis and transfections.	 The	 Cdc25A	
construct	 was	 generated	 by	 PCR	 from	 pGEX-4T-Cdc25A	 and	
cloned	 into	 the	 EcoRI	 restriction	 site	 of	 pCEFL-HA	 vector.	
pcDNA3-His6-Myc-hCdc14A	 was	 provided	 by	 J.	 Lukas.	 The	
Cdc14A	 phosphatase-dead	 version	 (C278S)	 and	 all	 the	 S/E	
Cdc25A	 mutants	 (S115E,	 S320E,	 S115/320E,	 S17/115E,	 and	
S17,115,320E)	 were	 generated	 using	 QuikChange	 Site-directed	
mutagenesis	 (Stratagene),	 according	 to	 manufacturer´s	 protocols.	
The	pCMV-GFP	construct	was	from	F.	Pimentel.	293-T	cells	were	
transfected	 using	 Lipofectamine	 2000	 (Invitrogen)	 and	 harvested	
40h	post-transfection.	To	monitor	transfection	efficiency	and	protein	
loading,	 0.8	 mg	 of	 pCMV-GFP	 was	 included	 in	 each	 transfec-
tion.	The	 following	 antibodies	 were	 used:	 anti-Cdc25A	 (F6;	 Santa	
Cruz);	anti-Cdc14A	(NeoMarkers-Lab	Vision)	anti-GFP	(JL-8;	BD	
Biosciences).
rESultS AND DiSCuSSioN
While	many	aspects	have	been	described	concerning	the	function	
of	Cdc14	and	the	molecular	mechanisms	by	which	this	phosphatase	
acts	regulating	cell	division	in	the	budding	yeast	S. cerevisiae,	little	is	
known	about	the	cellular	processes	carried	out	by	Cdc14	homologues	
in	human	cells.	We	have	previously	described	 that	 the	 two	human	
Cdc14	isoforms	are	able	to	complement	the	lack	of	the	flp1/clp1+	gene	
in	 S. pombe	 and	 that	 human	 Cdc14A	 dephosphorylates	 SpCdc25	
Figure 1. Human Cdc14A dephosphorylates in vitro Cdc25A previously 
phosphorylated by Cdk1/Cyclin‑B1. (A) GST‑Cdc25A purified from E. 
coli was phosphorylated in vitro by the Cdk1/Cyclin‑B1 complex and 
subsequently used in a phosphatase assay with three increasing amounts 
of GST‑Cdc14A, the catalytically inactive GST‑Cdc14A(CS) form, or buffer 
alone as control. Reactions were separated by SDS‑PAGE and analyzed 
by autoradiography (upper panel) and Coomassie blue staining (lower 
panel). (B) the relative amount of radioactive GST‑Cdc25A protein after 
the in vitro kinase and phosphatase assays was quantified. Bars show the 
means from three independent experiments of normalized ratio between 
32P‑GST‑Cdc25A radiactivity and the total amount of protein. 1X corre‑
sponds to the lowest amount of GST‑Cdc14A shown in (A), 2X corresponds 
to double the amount. (C) GST‑Cdc25A(101‑523), lacking the first 100 
N‑ terminal amino acids, was used as the Cdc14A phosphatase substrate 
as in A. The GST‑C‑terminal fragment of Cdc25A was phosphorylated by 
Cdk1/Cyclin‑B1 complex and subsequently incubated with two amounts of 
GST‑Cdc14A, GST‑Cdc14A‑(CS), or buffer alone. The levels of phosphory‑
lated and total GST‑fusion protein were detected by autoradiography and 
Coomassie blue staining respectively.
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protein	 to	 deprotect	 it	 from	 degradation19	 in	 a	 similar	 manner	 to	
Flp1/Clp1	does	in	fission	yeast.7,8	In	the	present	work,	we	wondered	
whether	 Cdc14A	 was	 able	 to	 dephosphorylate	 human	 Cdc25A,	
a	 critical	 regulator	 of	 the	 cell	 cycle	 progression,	 involved	 in	 both	
S-phase	and	mitotic	cellular	events	and	whose	contribution	to	G2/M	
transition	requires	its	stability	at	this	point	of	the	cell	cycle	by	mitotic	
CDK	phosphorylation.26	To	this	end,	we	used	purified	GST-Cdc14A	
and	Cdk1/Cyclin-B1-phosphorylated	GST-Cdc25A	in	some	in	vitro	
phosphatase	 assays.	 As	 shown	 in	 Figure	 1A	 and	 B,	 Cdc14A,	 but	
not	its	catalytically	inactive	form,	Cdc14A-CS,	was	able	to	dephos-
phorylate	Cdc25A.	It	has	been	described	that	in	mitosis	Cdc25A	is	
phosphorylated	by	Cdk1/Cyclin-B1	on	two	specific	residues:	serine	
17	 and	 serine	 115.26	 In	 order	 to	 study	 whether	 these	 two	 known	
Cdc2/CyclinB1-dependent	phosphate	 groups	 could	be	 removed	by	
Cdc14A,	we	dissected	the	Cdc25A	protein	into	two	fragments,	one	of	
them	corresponding	to	the	first	100	N-amino	terminal	residues,	where	
Ser17	is	included,	and	a	second	construct	comprising	the	rest	of	the	
protein,	the	GST-Cdc25A(101-523)	mutant,	which	contains	the	Ser115	
residue.	We	then	assayed	the	ability	of	Cdc14A	to	dephosphorylate	
these	 two	 GST-Cdc25A	 constructs	 and	 found	 that	 the	 C-terminal	
GST-Cdc25A(101-523)	 mutant	 was	 efficiently	 dephosphorylated	 by	
GST-Cdc14A	(Fig.	1C).	However,	Cdc14A	did	not	dephosphorylate	
the	 N-terminal	 GST-Cdc25A(1-100)	 fragment	 (data	 not	 shown).	
These	 data	 indicated	 that	 Cdk1/Cyclin-B1-phosphorylated	 serine	
115	 might	 be	 a	 target	 of	 Cdc14A,	 but	 not	 the	 phosphate	 group	
of	 serine	 17.	 The	 negative	 result	 concerning	 the	
dephosphorylation	 of	 Ser17	 by	 Cdc14A	 was	 also	
checked	 by	 immunoblotting	 with	 a	 specific	 anti-
body	 to	 Ser17-phosphorylated	 Cdc25A	 (data	 not	
shown).
To	 identify	 the	 specific	 Cdk1/Cyclin-	
B1-dependent	phosphorylated	residues	of	Cdc25A	
targeted	 by	 Cdc14A,	 we	 set	 up	 a	 kinase/phos-
phatase	 assay	 as	 described	 in	 Figure	 1,	 followed	
by	 a	 mass	 spectrometric	 analysis	 to	 detect	 phos-
pho-amino	 acids.	 We	 found	 that	 serine	 115	 and	
serine	 320	 were	 dephosphorylated	 by	 Cdc14A	
(Fig.	2A).	Unexpectedly,	Ser320	is	a	new	identified	
in	vitro	residue	targeted	by	mitotic	Cdk1/Cyclin-B1	
complexes,	 that	 can	 also	 be	 removed	 by	 Cdc14A	
phosphatase.	 Next,	 we	 tested	 these	 two	 specific	
Cdc14A	 dephosphorylation	 sites	 by	 additional	
in	 vitro	 kinase/phosphatase	 assays,	 using	 three	
full-length	 GST-Cdc25A	 mutants	 in	 which	 the	
serines	identified	(115	and	320)	were	substituted	by	
alanines.	While	the	two	individual	mutants	showed	
some	 level	 of	 dephosphorylation	 by	 Cdc14A,	 the	
mutation	 of	 both	 Ser115	 and	 Ser320	 appeared	
to	 abolish	 the	 Cdc14A	 dephosphorylation	 effect	
on	 Cdc25A	 (Fig.	 2B).	 Thus,	 human	 Cdc14A	
can	 dephosphorylate	 the	 Cdk1/Cyclin-B1	 phos-
phorylation	 sites	 of	 Cdc25A,	 Ser115	 and	 Ser320	
in	vitro.
Cdc25A	 is	 an	 unstable	 protein	 that	 is	
subject	 to	 constant	 turnover	 in	 cycling	 cells	 by	
periodic	 synthesis	 and	 ubiquitin-mediated	 prote-
olysis.	 It	 first	 appears	 in	 late	 G1	 as	 a	 result	
of	 E2F-1-	 and	 c-Myc-mediated	 transcriptional	
activation27-29	 after	 which	 it	 accumulates	 until	
mitosis.	 Counterbalancing	 the	 de	 novo	 synthesis,	
the	ubiquitin	ligase	complexes	APC/CCdh1,	upon	exit	from	mitosis,	
and	SCFbTrCP,	during	 interphase	and	upon	DNA	damage,	mediate	
its	 ubiquitin-proteasome	 degradation.30,31	 Moreover,	 multiple	
phosphorylation	sites	of	Cdc25A	by	several	kinases	 seem	to	 tightly	
regulate	 its	 degradation	 mechanisms	 and	 the	 final	 protein	 levels,	
which	could	afford	the	cell	different	thresholds	of	activity,	depending	
on	 the	 cell	 cycle	 phase	 or	 stress-induced	 situations	 (reviewed	 in	
ref.	32).
As	mentioned	above,	the	phosphorylation	of	serines	17	and	115	
by	Cdk1/Cyclin-B1	appears	to	be	crucial	for	the	stability	of	Cdc25A	
at	 the	 G2/M	 transition.
26	 According	 to	 these	 data	 and	 our	 own	
results,	 the	dephosphorylation	of	Cdc25A	by	Cdc14A,	particularly	
on	Ser115	and	Ser320	residues,	could	be	involved	in	the	regulation	
of	 Cdc25A	 stability.	 In	 order	 to	 check	 this	 possibility,	 we	 cotrans-
fected	 293-T	 cells	 with	 wild-type	 Cdc25A	 or	 different	 Cdc25A	
mutant	forms	(S115E,	S320E	and	S115/320E),	in	which	serines	115	
and	320	had	been	substituted	by	a	phosphomimicking	amino	acid	
-glutamic	acid-	 together	with	either	Cdc14A	or	an	empty	plasmid,	
and	we	then	tested	Cdc25A	protein	accumulation.	We	observed	that	
under	these	experimental	conditions	the	overexpression	of	Cdc14A,	
but	 not	 of	 the	 phosphatase-dead	 form	 Cdc14A-CS,	 resulted	 in	 a	
significant	 decrease	 in	 the	 level	 of	 wild-type	 Cdc25A	 (Fig.	 3A).	
This	 effect	 was	 also	 observed	 in	 both	 individual	 mutants,	 S115E	
or	S320E,	but	was	very	reduced	in	the	double	mutant	S115/320E,	
whose	protein	level	was	much	less	affected	by	the	overexpression	of	
Figure 2. Cdc14A reverses the Cdk1/Cyclin‑B1 phosphorylation of serines 115 and 320 of 
Cdc25A protein. (A) Total ion chromatogram of the precursor ion scanning of the phosphate 
group in negative mode at 79 Da. GST‑Cdc25A protein was phosphorylated by Cdk1/Cyclin‑B1 
complex (two peaks in upper panel), subsequently dephosphorylated by Cdc14A phosphatase 
(lower panel) and analyzed by triple‑quadrupole hybrid mass spectrometry for phosphorylation 
state. The ions corresponding to each chromatographic peak were fragmented and the phos‑
phorylation sites were characterized (underlined residues). (B) Two individual mutants (S115A 
and S320A) and a double (S115/320A) mutant of GST‑Cdc25A containing one or both serine 
residues substituted by alanine were used as substrates of Cdc14A phosphatase. Two amounts 
of GST‑Cdc14A were used (+ and ++).
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Cdc14A	(Fig.	3B).	These	results	suggest	that	Cdc14A	activity	would	
be	involved	in	some	Cdc25A	regulatory	mechanism,	acting	at	least	in	
part	through	the	dephosphorylation	of	Ser115/Ser320	residues.	We	
then	tested	whether	overexpression	of	Cdc14A	affected	 the	protein	
levels	of	a	Cdc25A	mutant	in	which	serines	17	and	115,	whose	phos-
phorylation	is	crucial	for	mitotic	Cdc25A	stability,	had	been	mutated	
to	 glutamic	 acid	 (S17/115E).	 Figure	 3C	 shows	 that	 although	 the	
stability	of	this	mutant	was	higher	than	that	of	the	wild-type	under	
Cdc14A	 overexpressing	 conditions,	 cells	 overexpressing	 Cdc14A	
accumulated	 lower	 levels	 of	 this	 Cdc25A	 mutant	 than	 controls.	
Finally,	 when	 S320	 was	 also	 mutated	 to	 obtain	 a	 triple	 S17/115/
320E	mutant	(3E),	the	overexpression	of	Cdc14A	had	a	smaller	effect	
and	the	Cdc25A	mutant	protein	level	remained	more	stable.	These	
results	are	consistent	with	the	interpretation	that	Cdc14A	would	be	
able	to	dephosphorylate	Cdc25A	in	vivo	on	at	least	S115	and	S320	
in	order	 to	 regulate	 its	 cellular	 levels	during	 the	cell	division	cycle,	
counteracting	Cdk1/Cyclin-B1	activity	on	the	mitotic	inducer.
Both	 the	 lability	 and	 stability	of	Cdc25A	protein	 rely	on	phos-
phorylation	 of	 certain	 specific	 amino-acid	 residues.	 It	 has	 been	
shown	that	the	phosphorylation-dependent	degradation	of	Cdc25A	
occurs	in	both	normal	interphase	cells	and	S-phase	cells	subjected	to	
different	 stress	 conditions.33-38	Thus,	 a	 fixed	 threshold	 of	 Cdc25A	
activity	is	maintained	in	a	normal	cell	cycle,	and,	in	response	to	cell	
damage,	 the	 accelerated	 phosphorylation-dependent	 degradation	
of	 Cdc25A	 induces	 the	 inactivation	 of	 CDK	 complexes	 and	 the	
consequent	 arrest	 of	 cell	 division.	 Mitotic	 stabilization	 of	 Cdc25A	
also	requires	some	phosphorylation	events.	Thus,	at	around	the	G2/
M	transition	Cdc25A	switches	from	a	labile	to	a	stable	form	through	
Cdk1/Cyclin-B1	phosphorylation.26	As	a	result	of	this,	CDK	activity	
peaks,	 leading	 to	 entry	 into	 mitosis.	 Later	 on,	 at	 the	 mitotic	 exit	
and	 early	 G1	 Cdc25A	 is	 degraded	 in	 an	 APC/C
Cdh1-dependent	
manner30	 at	 the	 time	 when	 Cdk1/Cyclin-B1	 activity	 drops.	 Here	
we	 report	 that	 in	 vitro	 Cdc14A	 is	 able	 to	 dephosphorylate	 Cdk1/
CyclinB1-dependent	 Cdc25A	 phosphorylated	 Serine	 115	 and	 320	
residues	 and	 that	 overexpression	 of	 Cdc14A	 induces	 Cdc25A	
degradation	 in	 a	 dephosphorylation-dependent	 manner.	 Our	 work	
suggests	 that	 Cdc14A	 may	 be	 involved	 in	 the	 control	 of	 the	 cell	
cycle-	regulated	Cdc25A	stability.
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